BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1217 related articles for article (PubMed ID: 27531851)

  • 41. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 42. Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion.
    Jain A; Malhotra S; Marwaha N; Kumar P; Sharma RR
    Asian J Transfus Sci; 2018; 12(2):176-179. PubMed ID: 30692807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ABO hemolytic disease.
    Cook LN
    Clin Obstet Gynecol; 1982 Jun; 25(2):333-9. PubMed ID: 7105509
    [No Abstract]   [Full Text] [Related]  

  • 44. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of multiple nursing interventions (cluster nursing) in ABO hemolytic disease of neonates and evaluation of its effect.
    Wang W; Tang C; Ji QL; Xiu H; Shao H; Yu XM
    J Int Med Res; 2020 Jan; 48(1):300060519887630. PubMed ID: 31939321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying ABO incompatibility in newborns: selective vs automatic testing.
    Madlon-Kay DJ
    J Fam Pract; 1992 Sep; 35(3):278-80. PubMed ID: 1517724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hemolytic disease of the newborn due to ABO incompatibility. A predictive test].
    Arévalo C; Herrmann F; Aguirre E; Vera J
    Rev Med Chil; 1992 Feb; 120(2):163-7. PubMed ID: 1340554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the direct antiglobulin (Coombs') test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs' test with ETCOc for detecting significant jaundice.
    Herschel M; Karrison T; Wen M; Caldarelli L; Baron B
    J Perinatol; 2002; 22(5):341-7. PubMed ID: 12082466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monogamous bivalency of IgG antibodies. I. Deficiency of branched ABHI-active oligosaccharide chains on red cells of infants causes the weak antiglobulin reactions in hemolytic disease of the newborn due to ABO incompatibility.
    Romans DG; Tilley CA; Dorrington KJ
    J Immunol; 1980 Jun; 124(6):2807-11. PubMed ID: 7189535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct antiglobulin test in the differential diagnosis of ABO hemolytic disease of the newborn: an important tool with high negative predictive value.
    Abbas SA; Dinardo CL; Godinho CH; Ziza K; Cruz B; Martins JO; Moritz E; Langui DM; Bordin JO
    Hematol Transfus Cell Ther; 2024 Apr; ():. PubMed ID: 38719716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ABO hemolytic disease of the newborn: evaluation of management and identification of racial and antigenic factors.
    Peevy KJ; Wiseman HJ
    Pediatrics; 1978 Mar; 61(3):475-8. PubMed ID: 565506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)].
    Fischer K; Poschmann A; Grundmann A
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ABO haemolytic disease: sex ratio and blood groups in the newborns requiring treatment.
    Hodr R
    Czech Med; 1989; 12(3):125-33. PubMed ID: 2509171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe hemolytic disease of the newborn caused by anti-Gonzales antibody.
    Leschek E; Pearlman SA; Boudreaux I; Meek R
    Am J Perinatol; 1993 Sep; 10(5):362-4. PubMed ID: 8240594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blocked D phenomenon and relevance of maternal serologic testing.
    Jain A; Kumawat V; Marwaha N
    Immunohematology; 2015; 31(3):116-8. PubMed ID: 26829177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical value of combination detection of direct antiglobulin test and serum albumin globulin ratio in severe hyperbilirubinemia caused by ABO hemolytic disease of the newborn.
    Duan L; Chen P; Tu N; Hu H
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2228965. PubMed ID: 37369373
    [No Abstract]   [Full Text] [Related]  

  • 58. ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases.
    Dufour DR; Monoghan WP
    Am J Clin Pathol; 1980 Mar; 73(3):369-73. PubMed ID: 7189092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immuno-hematological diagnosis of materno-fetal ABO isoimmunization parallel studies on 269 mother-infant pairs].
    Armenio L; Ceci A; De Simone B
    Pediatria (Napoli); 1971; 79(1):88-101. PubMed ID: 5097732
    [No Abstract]   [Full Text] [Related]  

  • 60. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.